Sign in

Trial result ·

Tetrahydrocannabinol/cannabidiol in the treatment of restless legs syndrome.

Written based on 1 research study on PubMed, searched on 13 Nov 2026.

What was studied

This study tested a THC and CBD drug for restless legs syndrome (RLS). Each dose mixed 2.7 mg THC with 2.5 mg CBD. People with RLS took it for 3 months. Of the people in the study, 16 also had multiple sclerosis (MS). Everyone knew which drug they were taking. Symptom scores were taken at the start, week 4 and week 12. Sleep was tracked for 14 days at the start and again at week 12.

What they found

At the start, the people had severe RLS. Their RLS scores got better after 1 month on the drug. The scores were also better after 3 months. Time spent awake after first falling asleep went down. Time taken to fall asleep did not change much. The share of time in bed spent asleep did not change much. After 1 year, some people were still taking the drug. Their RLS scores stayed better.

What it means for patients

The authors say this drug eased RLS in this group. Of the people in the group, 16 had MS. Gains showed up after 1 and 3 months. They lasted for 1 year in people who kept taking it. The study was meant as a first look, not a final test.

Why it is not certain yet

This was an early, exploratory study. Of the people in it, 16 had MS. Everyone knew they were getting the drug. In this kind of study, that can shape how people rate symptoms. The abstract does not mention a comparison group. Not everyone stayed on the drug for 1 year. The abstract does not describe side effects.

Source

Tetrahydrocannabinol/cannabidiol in the treatment of restless legs syndrome.

PubMed · PMID 42387200

We restate facts from the source record in our own words. The original wording belongs to its publisher.

This page is not medical advice. Talk to your doctor about your own care.

Back to Restless legs syndrome publications